Table 1 Patients´ characteristics

Median Age (years, range)

74 (59–82)

Gleason Score n (%)

Low risk (≤6)

5 (33.3)

Intermediate risk (7)

4 (26.7)

High risk (>7)

6 (40.0)

Serum PSA (ng/ml) n (%)

Low risk (≤10)

7 (46.7)

Intermediate risk (10–20)

3 (20.0)

High risk (>20)

5 (33.3)

Initial tumor stage (clinical examination and CT/MRI), n (%)

Biopsy T1c

7 (46.7)

Intermediate risk (T2b)

1 (6.7)

High risk (≥T2c)

7 (46.7)